Review of CCNU in clinical cancer therapy
- 30 June 1974
- journal article
- review article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 1 (2), 131-151
- https://doi.org/10.1016/s0305-7372(74)80015-0
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Glioblastoma multiforme—A review of therapyCancer Treatment Reviews, 1974
- Chloroethyl-cyclohexyl-nitrosourea (CCNU) in the treatment of malignant brain tumorsJournal of Neurosurgery, 1973
- EORTC protocol for the study of CCNU in the treatment of irradiated, operated, malignant glioma of the brainEuropean Journal of Cancer (1965), 1973
- Lomustine treatment of metastatic renal cell carcinomaJAMA, 1973
- Pancreatic Islet Cell CarcinomaAnnals of Internal Medicine, 1973
- 1-(2-Chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU, NSC-79037): A comparison of drug administration at four-week and six-week intervalsEuropean Journal of Cancer (1965), 1973
- A strategy of chemotherapeutic eradication based upon correlative variations in total cell population, growth fraction and resistanceEuropean Journal of Cancer (1965), 1972
- A toxicologic comparison of the potency and activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) in mice and ratsToxicology and Applied Pharmacology, 1972
- Duration of Drug Levels in Mice as Indicated by Residual Antileukemic EfficacyChemotherapy, 1968
- Alkylating Activity of 1,3-Bis(2-chloroethyl)-1-nitrosourea and Related CompoundsJournal of Medicinal Chemistry, 1967